Literature DB >> 15959947

Why big pharma needs to learn the three 'R's.

David Bradley.   

Abstract

Mesh：

Year:  2005        PMID： 15959947     DOI： 10.1038/nrd1766

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

Review 1.  Recycled Translation: Repurposing Drugs for Stroke.

Authors:  Samantha E Spellicy; David C Hess
Journal:  Transl Stroke Res       Date:  2022-02-26       Impact factor: 6.829

2.  Ivermectin is a nonselective inhibitor of mammalian P-type ATPases.

Authors:  Paulo Henrique Cotrim Pimenta; Claudia Lucia Martins Silva; François Noël
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-30       Impact factor: 3.000

Review 3.  Drug repositioning for personalized medicine.

Authors:  Yvonne Y Li; Steven Jm Jones
Journal:  Genome Med       Date:  2012-03-30       Impact factor: 11.117

4.  Genome-wide discovery of hidden genes mediating known drug-disease association using KDDANet.

Authors:  Hua Yu; Lu Lu; Ming Chen; Chen Li; Jin Zhang
Journal:  NPJ Genom Med       Date:  2021-06-15       Impact factor: 8.617
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.